Physician profile
John Lydon
NPI 1851685713
$6,922.57
in general payments reported to CMS, 2019-2025
14 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $6,347 · 2022: $128 · 2023: $116 · 2024: $53.72 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.95 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,347.09 | 2020 | |
| Sumitomo Pharma America, INC. | $111.98 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $75.68 | 2024-2025 | Veozah |
| Pfizer INC. | $71.54 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $59.34 | 2022-2025 | |
| Organon LLC | $47.08 | 2022-2025 | Jada System |
| Hologic Sales and Service, LLC | $36.52 | 2023 | Coolseal Generator |
| Abbvie INC. | $35.14 | 2022-2025 | |
| Optumhealth Care Solutions, LLC | $33.22 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $32.47 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $23.04 | 2022 | |
| Amgen INC. | $20.02 | 2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $15.61 | 2022 | |
| Tactile Systems Technology INC | $13.84 | 2023 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lydon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.